CHONA GREEN: Open Payments
NPI 1437219441 · LAGUNA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 78 payments from 14 companies in 2025. Trend: 2023 $1,407 · 2024 $862 · 2025 $1,731
Food & beverage: $1,724Education: $7
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $321 |
| Vanda Pharmaceuticals Inc. | 12 | $300 |
| Otsuka America Pharmaceutical, Inc. | 14 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $153 |
| Axsome Therapeutics, Inc. | 7 | $152 |
| Alkermes, Inc. | 6 | $139 |
| Janssen Pharmaceuticals, Inc | 4 | $103 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
Products named: CAPLYTA, REXULTI, HETLIOZ, TRINTELLIX, Auvelity, ARISTADA, SPRAVATO, FANAPT.
Industry payments across CA — which companies pay providers there.
